Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

Journal of Infectious Diseases

Volumn 202, Issue 10, 2010, Pages 1562-1566

  Koehler, Rebecca N ^a   Walsh, Anne M ^a   Saathoff, Elmar ^c   Tovanabutra, Sodsai ^a   Arroyo, Miguel A ^b   Currier, Jeffery R ^a   Maboko, Leonard ^d   Hoelsher, Michael ^c,d   Robb, Merlin L ^a   Michael, Nelson L ^b   McCutchan, Francine E ^a,e   Kim, Jerome H ^b   Kijak, Gustavo H ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d Mbeya Medical Research Programme   (Tanzania)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

AFRICA; ALLELE; ANTIGENIC VARIATION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; TANZANIA;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HUMANS; MALE; TANZANIA;

EID: 78349245591     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656913     Document Type: Article

References (15)

1. Stephens HA. HIV-1 diversity versus HLA class I polymorphism. Trends Immunol 2005; 26:41-47.
2. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283:1748-1752.
3. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655.
4. Kijak GH, Walsh AM, Koehler RN, et al. HLA class I allele and haplotype diversity in Ugandans supports the presence of a major East African genetic cluster. Tissue Antigens 2009; 73:262-269.
5. Koehler RN,Walsh AM, Sanders-Buell EE, et al. High-throughput high-resolution class I HLA genotyping in East Africa. PLoS One 2010; 5:e10751.
6. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432:769-775.
7. Kawashima Y, Pfafferott K, Frater J, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009; 458:641-645.
8. Arroyo MA, Hoelscher M, Sateren W, et al. HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 2005; 19:1517-1524.
9. Tang J, Malhotra R, Song W, et al. Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS One 2010; 5:e9629.
10. MacDonald KS, Fowke KR, Kimani J, et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000; 181:1581-1589.
11. Saathoff E, Pritsch M, Geldmacher C, et al. Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania. J Acquir Immune Defic Syndr 2010; 54(3):324-330.
12. Lazaryan A, Song W, Lobashevsky E, et al. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol 2010; 84:2610-2617.
13. Sidney J, Peters B, Frahm N, Brander C, Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol 2008; 9:1.
14. Fellay J, Ge D, Shianna KV, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791.
15. Farquhar C, Rowland-Jones S, Mbori-Ngacha D, et al. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses 2004; 20:692-697.